How SGS Supports Cell & Gene Therapy Manufacturing

[Article Title]

The manufacturing of Cell and Gene Therapy (C&GT) products requires a thorough testing process, which must include critical aspects such as safety, identity, strength/potency, purity, and quality. SGS meets the analytical requirements across all these categories, providing expertise in development (de novo), transfer, stability, and release. Download this infographic for more information on how SGS supports C&GT manufacturing.

Download Document

    Please fill out the information below. If you are already registered or have requested a quote before, and this information will be filled out for you.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

  • By downloading this content, I agree that SGS can use my data for the purposes of dealing with my request, in accordance with the SGS Online Privacy Statement. SGS may also contact me with information on webinars, news, and events, and their experts can contact me about cell and gene therapy testing solutions.

  • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information, transmitting your contact information to selected trusted partners, and customizing your experience based on the data you enter.